secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-08-03T12:34:24+00:00
Accession:  0001104659-26-089524
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus and Indivior file investor presentation for proposed merger of equals; terms undisclosed
--------------------------------------------------------------------------------

- Conference call held August 3, 2026 at 8:30 a.m. ET to discuss merger of equals.
- Merger of equals aims to create a diversified CNS biopharmaceutical leader with significant scale.
- Forward-looking statements reference a special dividend funded by additional indebtedness; amount not specified.
- Indivior to file Form S-4 with joint proxy statement/prospectus for stockholder vote.
- Investor presentation filed with SEC on August 3, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/0001104659-26-089524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000110465926089524/tm2622009d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-089524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer